NCT07806695PHASE1Recruiting
Islet Function in Gestational Diabetes
Mayo Clinic
Start Date
9/1/2026
Completion Date
12/1/2030
Summary
The purpose of this research is to understand how the function of the human pancreas changes during and after pregnancy.
Eligibility Criteria
Age Range: 20 years to 40 years
Inclusion Criteria:
* Pregnant individuals with a viable singleton pregnancy who have completed second trimester gestational diabetes screening and are eligible for classification as either gestational diabetes mellitus or no gestational diabetes mellitus.
* Participants must be willing and able to provide informed consent and complete planned pregnancy and postpartum study visits.
Exclusion Criteria:
* Active systemic illness (e.g. chronic kidney disease, hypertension)
* Pre-pregnancy diabetes mellitus
* Multiple gestation, major fetal anomaly, or non-viable pregnancy on ultrasound
* Fasting glucose ≥ 100 mg/dL or HbA1c ≥ 5.7% in early pregnancy
* One abnormal value on the 3-hour 100 g oral glucose tolerance test
* Glucose at least 190 mg/dL on glucose challenge testing without subsequent 3-hour oral glucose tolerance testing
* Use of medication affecting glucose metabolism before pregnancy or in early pregnancy
* Use of glucose-lowering medication (e.g. metformin, glyburide) other than insulin to treat gestational diabetes mellitus in the current pregnancy
* History of upper gastrointestinal surgery that alters gastric emptying (e.g. bariatric surgery)
* Hemoglobin \< than 11 g/dL
Interventions
DRUG
Exendin 9-39
Conditions
Gestational Diabetes Mellitus
Locations
Mayo Clinic
Rochester, Minnesota 55905
United States